🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Radioembolization

RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study NCT07345247n/a20 sites📍 Adana📍 Adana📍 Adana Ankara University Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT) NCT07312292Phase 21 site📍 Utrecht Niek Wijnen · Tests: Angiotensin II (Giapreza®), Yttrium-90 radioembolization 90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia NCT05953961NA1 site📍 New Orleans Ochsner Health System · Tests: Therasphere 90Y, Microwave Ablation Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer NCT06860815Phase 21 site📍 Duarte City of Hope Medical Center · Tests: Biopsy, Biospecimen Collection, Cemiplimab, Computed Tomography, Magnetic Resonance Imaging Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis NCT06166576Phase 25 sites📍 Ilsan📍 Seongnam-si📍 Seoul Seoul National University Hospital · Tests: Ablative radioembolization Introduction of Y90-PET-CT Post Radioembolisation Therapy Scans NCT06123676NA1 site📍 Manchester The Christie NHS Foundation Trust · Tests: Y90-PET-CT scan Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment NCT03686709NA1 site📍 Knoxville University of Tennessee · Tests: Post therapy PET/CT Imaging Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma NCT06873269n/a1 site📍 Brussels Universitair Ziekenhuis Brussel · Tests: Baseline assessment, holmium-166 radioembolization, Follow-up phase A Phase I Study of Intra-Arterial Yttrium-90 Radioembolization for Unresectable Pancreatic Cancer NCT07898683Phase 11 site📍 Obninsk National Medical Research Radiological Centre of the Minist… · Tests: Transarterial Radioembolization Streamlining Radioembolization for CCC and Metastatic Liver Cancer NCT07043387n/a4 sites📍 Goyang-si📍 Seoul📍 Seoul Seoul National University Hospital qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver NCT06971991NA1 site📍 Madison University of Wisconsin, Madison · Tests: qDSA Blood Flow Measurement Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments NCT06862934n/a1 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Same-day Radioembolization for Large HCC NCT06944483n/a4 sites📍 Goyang📍 Seoul📍 Seoul Seoul National University Hospital · Tests: same-day radioembolization Radioembolization Versus External Radiation Therapy NCT07530172Phase 21 site📍 Detroit Henry Ford Health System · Tests: Transarterial Radioembolization, Stereotactic Body Radiation Therapy (SBRT) Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH) NCT07293468Phase 2, Phase 31 site📍 Hong Kong Tuen Mun Hospital · Tests: Transarterial chemoembolization (TACE), Stereotactic Body Radiation Therapy (SBRT), SIRT Yttrium-90, Atezolizumab &… Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases NCT05195710Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Yttrium-90 (Y-90) resin microspheres Streamlining Radioembolization for Small HCC NCT06979219n/a5 sites📍 Goyang📍 Seongnam-si📍 Seoul Seoul National University Hospital Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90 NCT07303712n/a1 site📍 Palo Alto Palo Alto Veterans Institute for Research Y-90 Treatment Response Using Transarterial Radioembolization NCT07145801Phase 21 site📍 Philadelphia Thomas Jefferson University · Tests: Lumason, Sonazoid The AMARA (As Much As Reasonably Achievable) Study NCT06257030n/a1 site📍 Pátrai University Hospital of Patras · Tests: Transarterial Radioembolization Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria NCT06773845Phase 28 sites📍 Gangneung📍 Anyang-si📍 Ilsan Seoul National University Hospital · Tests: TheraSphere Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy NCT06375915Phase 24 sites📍 Bergamo📍 Milan📍 Naples Francesco De Cobelli · Tests: radioembolization with Y-90, Durvalumab, Cisplatin, Gemcitabine Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial NCT06432036Phase 1, Phase 22 sites📍 Los Angeles📍 Aurora Jonsson Comprehensive Cancer Center · Tests: Angiogram, Biospecimen Collection, Computed Tomography, Radioembolization, Single Photon Emission Computed Tomography Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma NCT06178198Phase 21 site📍 Seoul Seoul National University Hospital · Tests: Ablative radioembolization using Yttrium-90 resin microspheres Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant NCT07059494Phase 41 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Atezolizumab, Bevacizumab, Y^90 Radioembolization Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma NCT06627244Phase 21 site📍 Miami University of Miami · Tests: Tebentafusp, TheraSphere™ Yttrium-90 Trans-Arterial Radioembolization Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma NCT06058663Phase 11 site📍 Jacksonville Mayo Clinic · Tests: Angiography, Biopsy, Biospecimen Collection, Computed Tomography, Durvalumab FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer NCT06563986Phase 21 site📍 Utrecht UMC Utrecht · Tests: Systemic treatment (FTD-TPI and bevacizumab), Radioembolization with 166-Ho microspheres The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer NCT05422690Phase 21 site📍 Fairfax Inova Health Care Services · Tests: Induction Chemotherapy Triplet Therapy, Concurrent Y-90 treatment, Consolidation Doublet Therapy: A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE) NCT07252323NA1 site📍 Seoul Yonsei University · Tests: Carbon Ion Radiotherapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy